Candelanza, Mylyn B.
HRN: 01-98-57 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2023
AMPICILLIN 1GM (VIAL)
07/09/2023
07/10/2023
IV
2g
Now Then Q6
PROM
Waiting Final Action
07/09/2023
CEFUROXIME 500MG (TAB)
07/09/2023
07/15/2023
ORAL
500
BId
Rmle
Waiting Final Action